Skip to main content

Reviva Pharmaceuticals

Published

Jul 5, 2023

About this Series

Amplify Spotlight

The Nasdaq Issuer Spotlight interview series explores how industry leaders within small-cap community are evolving and navigating challenges in various industries.

In this Nasdaq Amplify Issuer Spotlight, we spoke with Dr. Laxminarayan Bhat Founder, President, and Chief Executive Officer of Cupertino based Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH). Dr. Bhat discusses Reviva’s pipeline and its commitment to developing better, safer, and more effective treatments for central nervous system, respiratory, and metabolic diseases of huge unmet need.

No transcript available

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/